Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Wedelolactone

Copy Product Info
😃Good
Catalog No. T3384Cas No. 524-12-9
Alias IKK Inhibitor II

Wedelolactone (IKK Inhibitor II) inhibits NF-κB-mediated gene transcription in cells by blocking the phosphorylation and degradation of IκBα.

Wedelolactone

Wedelolactone

Copy Product Info
😃Good
Purity: 99.87%
Catalog No. T3384Alias IKK Inhibitor IICas No. 524-12-9
Wedelolactone (IKK Inhibitor II) inhibits NF-κB-mediated gene transcription in cells by blocking the phosphorylation and degradation of IκBα.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$30In StockIn Stock
5 mg$68In StockIn Stock
10 mg$117In StockIn Stock
25 mg$195In StockIn Stock
50 mg$349In StockIn Stock
100 mg$459In StockIn Stock
500 mg$1,060InquiryInquiry
1 mL x 10 mM (in DMSO)$48In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.87%
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Wedelolactone AI Summary
Wedelolactone demonstrates a wide array of bioactivities, including inhibitory effects on key enzymes and molecular interactions. It inhibits 5-lipoxygenase in pig leukocytes with an IC50 of 2500000.0 nM and shows inhibitory activity against rat kidney Na+, K+-ATPase and rat brain synaptosomes flunitrazepam binding with IC50 values of 700.0 nM and 2000.0 nM respectively. Additionally, it stabilizes various protein targets such as kinases (e.g., AMPKA2, CAMKs, CDKs, etc.) via thermal melting changes. It binds human recombinant carbonyl reductase 1 and 3 with a notable increase in melting temperature in the presence of NADP+, and shows inhibitory effects on NADPH oxidation (IC50 of 3780.0 nM, Ki of 600.0 nM). The compound also inhibits HCV 1b NS5B polymerase with an IC50 of around 36100.0 nM. It inhibits Borrelia burgdorferi telomere resolvase and exhibits binding affinity to EED with a dissociation constant (Kd) of 2820.0 nM. Moreover, Wedelolactone shows moderate inhibition of AChE and BChE at 2 mg/ml concentrations and influences G6PD activity in human cells. It's a potent inhibitor of organic cation transporters OCT1 and OCT2, with significant inhibitory activity on OCT1-mediated ASP+ uptake. These diverse bioactivities underscore the potential of Wedelolactone as a multifaceted chemical tool for biological research and therapeutic development..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Wedelolactone (IKK Inhibitor II) inhibits NF-κB-mediated gene transcription in cells by blocking the phosphorylation and degradation of IκBα.
Targets&IC50
5-LOX:2.5 μM (IC50)
SynonymsIKK Inhibitor II
Chemical Properties
Molecular Weight314.25
FormulaC16H10O7
Cas No.524-12-9
SmilesCOc1cc(O)c2c3oc4cc(O)c(O)cc4c3c(=O)oc2c1
Relative Density.1.655 g/cm3
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 252.5 mg/mL (803.5 mM), Sonication is recommended.
Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5.7 mg/mL (18.14 mM), Solution.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1822 mL15.9109 mL31.8218 mL159.1090 mL
5 mM0.6364 mL3.1822 mL6.3644 mL31.8218 mL
10 mM0.3182 mL1.5911 mL3.1822 mL15.9109 mL
20 mM0.1591 mL0.7955 mL1.5911 mL7.9554 mL
50 mM0.0636 mL0.3182 mL0.6364 mL3.1822 mL
100 mM0.0318 mL0.1591 mL0.3182 mL1.5911 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Wedelolactone | purchase Wedelolactone | Wedelolactone cost | order Wedelolactone | Wedelolactone chemical structure | Wedelolactone formula | Wedelolactone molecular weight